三诺生物：收到四项《中华人民共和国医疗器械注册证》

Company Overview - Sanor Bio received four medical device registration certificates from the Hunan Provincial Drug Administration, including the "Blood Glucose and Ketone Analyzer" [1] - As of the first half of 2025, Sanor Bio's revenue composition is 99.66% from medical devices and 0.34% from other sources [1] - The current market capitalization of Sanor Bio is 9.5 billion yuan [1]